AI Article Synopsis
- The study found cumulative failure rates of 9.5% at six months, increasing to 46.0% after three years of follow-up after an additional AGV implant for glaucoma treatment.
- At the final follow-up, complete and qualified success rates were 23.8% and 33.3%, with a notable decrease in intraocular pressure (IOP) and medication usage.
- Common complications included a hypertensive phase (38.1%), corneal decompensation (23.8%), and tube exposure (14.3%), which require careful monitoring post-surgery.
Article Abstract
Results: The cumulative failure rates were 9.5%, 20.0%, 32.5%, and 46.0% at six months, one year, two years, and three years of follow-up. At final follow-up, complete success and qualified success rates were 23.8% and 33.3%, respectively; mean IOP and number of medications decreased by 5.6 mmHg (23.9%) and 1.7 mmHg (54.8%), respectively, from preoperative baseline ( < 0.01). More common postoperative complications included hypertensive phase (38.1%), corneal decompensation (23.8%), and tube exposure (14.3%).
Conclusion: An additional AGV implant had good short and modest long-term effectiveness in reducing IOP following a failed glaucoma tube shunt in Asian eyes, with the mentioned common postoperative complications to be actively monitored and managed.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125488 | PMC |
| http://dx.doi.org/10.1155/2020/8741301 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!